Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Enzalutamide Significantly Improves Progression-Free Survival in Men with Metastatic Prostate Cancer

A multi-institutional group of clinical researchers, led by Duke Cancer Institute’s Andrew Armstrong, MD, MSc, FACP, published a new report this month in the Journal of Clinical Oncology (JCO) that describes results from the ARCHES study. ARCHES prospectively studied and evaluated the efficacy and...

Study Finds How Prostate Cancer Cells Mimic Bone When They Metastasize

Prostate cancer often becomes lethal as it spreads to the bones, and the process behind this deadly feature could potentially be turned against it as a target for bone-targeting radiation and potential new therapies. In a study published online Tuesday in the journal PLOS ONE, Duke Cancer Institute...

Blood Tests Predict Effectiveness of Hormonal Therapies

A multi-institutional group of clinical researchers, led by the Duke Cancer Institute’s Andrew Armstrong, MD, McS, FACP, published a new report this month in the Journal of Clinical Oncology , that describes results from the PROPHECY study, which prospectively compared two blood tests to assess how...

C3O Drills Down On The Canine-To-Human Biomedical Pipeline

While there have been many successes with newer chemotherapies, targeted therapies, and immunotherapies, many cancer types in the human population don’t respond well to therapy. Of those disease types that do, the short-term and long-term toxicities to the body can be quite significant. There’s a...

Study Signals Survival Benefit for Black Men On New Prostate Cancer Drugs

It used to be a statistical fact that African-American men fared worse than whites when battling prostate cancer. But recent research led by scientists at the Duke Cancer Institute has been challenging that notion. Added evidence will be presented Feb. 11 at a meeting of the American Society of...

Suneja Receives NCI Career Development Award

Duke Cancer Institute’s Gita Suneja , MD, MSHP, has received a five-year National Cancer Institute Mentored Clinical Scientist Research Career Development Award (K08) for her project “Cancer Treatment Disparities in the HIV Population: Exploring the Impact of HIV on Physician and Patient Decision-...

Pain Management Via Skype Could Be Just What The Doctor Ordered

Preliminary results of a four-year study led by Duke Cancer Institute clinical psychologist Tamara Somers, PhD, appear to conclude that, when delivered via video chat, a cancer pain therapy protocol her team developed was more accessible than the same therapy delivered in an office setting. This...

Duke Researchers Awarded $1 Million For Prostate Cancer Research

A team of researchers led by Duke Cancer Institute's Steven Patierno, PhD; Daniel George, MD; Jennifer Freedman, PhD; Jiaoti Huang, MD, PhD and Amanda Hargrove, PhD have been awarded a Movember Foundation-Prostate Cancer Foundation Challenge Award. The project includes a number of key co-...

Get In The Game. Know Your Scores.

Get in the game — know your scores. Duke Cancer Institute's Office of Health Equity (OHE) and its partner Lincoln Community Health Center will offer FREE prostate cancer screenings on Saturday, Sept. 8, and Sunday, Sept. 9. Men between the ages of 45 and 75, who have never been diagnosed with...

Sound Waves Could Provide New Tool To Fight Cancer

Sound waves may become the next effective tool to help doctors diagnose cancer and develop more personalized diagnostics and treatments. A new study conducted by researchers from Duke University, MIT and Singapore's Nanyang Technological University shows that sound waves are capable of rapidly and...

Tests Identify When Advanced Prostate Cancer Therapies Would Benefit

Two blood tests can predict which subset of men with advanced prostate cancer will likely not benefit from anti-androgen therapies, providing doctors and patient added clarity on treatment options, according to a study led by Duke Cancer Institute. The blood tests, dubbed “liquid biopsies”, detect...

Analysis: Survival Benefit for African-Americans with Advanced Prostate Cancer

Contrary to current perceptions, certain African-American men with advanced prostate cancer have as good a chance of survival as white men and might actually have a small advantage, according to a new analysis of more than 8,000 patients who participated in clinical trials. In a study presented...

Pages